NTLA
Intellia Therapeutics, Inc. · Healthcare
President and CEO John M Leonard sold $566K of Intellia Therapeutics, Inc.
Sold$566,310
$29.46Price
19,223Shares
−2%Stake
What NTLA did after the filing
- The stock from Mon, Jan 8 open, $28.18
- −4.6%
- S&P 500, same days
- +6.1%
Measured over 30 trading days, to the Feb 21 close.
Traded Wed, Jan 3. Filed Fri, Jan 5, 4:51 PM ET, after the close. Returns use the Jan 8 open and the Feb 21 close. Not investment advice.